CAR T-cell therapy for B-cell lymphoma

Denlinger, N; Bond, D; Jaglowski, S

Denlinger, N (通讯作者)，Ohio State Univ, Dept Internal Med, Div Hematol, 518 Biomed Res Tower, Columbus, OH 43210 USA.

CURRENT PROBLEMS IN CANCER, 2022; 46 (1):

Abstract

Chimeric antigen receptor-modified (CAR) T-cell therapy targeting CD19 has revolutionized the treatment of relapsed or refractory B-cell lymphomas. Ba......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索